You are in the accessibility menu

Please use this identifier to cite or link to this item: http://acervodigital.unesp.br/handle/11449/19996
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPavon, Lorena Favaro-
dc.contributor.authorMarti, Luciana Cavalheiro-
dc.contributor.authorSibov, Tatiana Tais-
dc.contributor.authorMalheiros, Suzana M. F.-
dc.contributor.authorOliveira, Daniela Mara-
dc.contributor.authorGuilhen, Daiane Donna-
dc.contributor.authorCamargo-Mathias, Maria Izabel-
dc.contributor.authorAmaro Junior, Edson-
dc.contributor.authorGamarra, Lionel Fernel-
dc.date.accessioned2014-05-20T13:55:49Z-
dc.date.available2014-05-20T13:55:49Z-
dc.date.issued2010-06-01-
dc.identifierhttp://dx.doi.org/10.1089/cbr.2009.0697-
dc.identifier.citationCancer Biotherapy and Radiopharmaceuticals. New Rochelle: Mary Ann Liebert Inc., v. 25, n. 3, p. 289-298, 2010.-
dc.identifier.issn1084-9785-
dc.identifier.urihttp://hdl.handle.net/11449/19996-
dc.description.abstractDespite recent advances, patients with malignant brain tumors still have a poor prognosis. Glioblastoma (WHO grade 4 astrocytoma), the most malignant brain tumor, represents 50% of all astrocytomas, with a median survival rate of <1 year. It is, therefore, extremely important to search for new diagnostic and therapeutic approaches for patients with glioblastoma. This study describes the application of superparamagnetic nano-particles of iron oxide, as well as monoclonal antibodies, of immunophenotypic significance, conjoined to quantum dots for the ultrastructural assessment of glioblastoma cells. For this proposal, an immunophenotypic study by flow cytometry was carried out, followed by transmission electron microscopy analysis. The process of tumor cell labeling using nanoparticles can successfully contribute to the identification of tumorigenic cells and consequently for better understanding of glioblastoma genesis and recurrence. In addition, this method may help further studies in tumor imaging, diagnosis, and prognostic markers detection.en
dc.description.sponsorshipInstituto Israelita de Ensino e Pesquisa Albert Einstein-
dc.description.sponsorshipSociedade Beneficente Israelita Brasileira Hospital Albert Einstein (SBIBHAE)-
dc.format.extent289-298-
dc.language.isoeng-
dc.publisherMary Ann Liebert, Inc.-
dc.sourceWeb of Science-
dc.subjectcancer diagnosisen
dc.subjectglioblastomaen
dc.subjectimmunolocalizationen
dc.subjectmarkersen
dc.subjectnanoparticlesen
dc.subjectultrastructuralen
dc.titleThe Ultrastructural Study of Tumorigenic Cells Using Nanobiomarkersen
dc.typeoutro-
dc.contributor.institutionSBIBHAE-
dc.contributor.institutionIIEPAE-
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)-
dc.contributor.institutionUniversidade Federal de São João del-Rei (UFSJ)-
dc.contributor.institutionUniversidade Estadual Paulista (UNESP)-
dc.contributor.institutionUniversidade de São Paulo (USP)-
dc.description.affiliationSBIBHAE, INCE, IIEPAE, BR-05651901 São Paulo, Brazil-
dc.description.affiliationIIEPAE, Ctr Pesquisa Expt, São Paulo, Brazil-
dc.description.affiliationUniv Fed São Paulo, Dept Neurol & Neurochirurg, São Paulo, Brazil-
dc.description.affiliationUniv Fed Sao Joao Del Rei, Sao Joao Del Rei, Brazil-
dc.description.affiliationUNESP, Dept Biol, Inst Biociencias, Rio Claro, Brazil-
dc.description.affiliationUniv São Paulo, Dept Radiol, São Paulo, Brazil-
dc.description.affiliationUnespUNESP, Dept Biol, Inst Biociencias, Rio Claro, Brazil-
dc.description.sponsorshipIdInstituto Israelita de Ensino e Pesquisa Albert Einstein: IIEP/278-07-
dc.identifier.doi10.1089/cbr.2009.0697-
dc.identifier.wosWOS:000279177300005-
dc.rights.accessRightsAcesso restrito-
dc.identifier.fileWOS000279177300005.pdf-
dc.relation.ispartofCancer Biotherapy and Radiopharmaceuticals-
Appears in Collections:Artigos, TCCs, Teses e Dissertações da Unesp

There are no files associated with this item.
 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.